https://www.marketscreener.com/quote/stock/VYNE-THERAPEUTICS-INC-40331628/news/VYNE-Therapeutics-Reports-Positive-Results-from-Preclinical-Models-for-Oral-BD2-Selective-BET-Inhibi-45184359/?utm_source=telegram&utm_medium=social&utm_campaign=share